Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

2869 - Survival outcome and optimal treatment of intermediate-grade salivary gland carcinoma

Date

10 Sep 2017

Session

Poster display session

Topics

Cancers in Adolescents and Young Adults (AYA);  Head and Neck Cancers

Presenters

GICHEOL PARK

Citation

Annals of Oncology (2017) 28 (suppl_5): v372-v394. 10.1093/annonc/mdx374

Authors

G. PARK

Author affiliations

  • Otolaryngology, Samsung Changwon Hospital Sung Kyun Kwan University, 630-723 - Changwon/KR
More

Resources

Abstract 2869

Background

Histological grade is the most important factor for defining treatment strategies and predicting prognosis for salivary gland carcinoma (SGC). Although several studies have addressed low- and high-grade SGCs, intermediate-grade SGC (IGSGC) has received minimal attention. Therefore, we examined factors affecting long-term recurrence and survival among IGSGC patients to define optimal treatment modalities and outcomes.

Methods

We reviewed the clinical and pathological data of 108 IGSGC patients who underwent definitive surgery with or without postoperative radiotherapy at our tertiary referral center between 1994 and 2014. We performed univariate and multivariate analyses of variables predictive of locoregional control (LRC), distant metastasis-free survival (DMFS), and overall survival (OS). We compared treatment outcomes by treatment strategies such as surgical extent, primary tumor, neck dissection, or postoperative radiotherapy.

Results

During a median 103 (range, 24–282)-month follow-up, local, regional, and distant recurrences were detected in 14 (13.0%), 3 (2.8%), and 21 (19.4%) patients, respectively. The 10-year LRC, DMFS, and OS rates were 83.1%, 76.0%, and 80.1%, respectively. Multivariate analyses identified a non-parotid primary site as an independent prognostic factor for LRC (P = 0.018), Adenoid cystic carcinoma and positive pN classification were significantly unfavorable prognostic factors for DMFS (P = 0.025 and P = 0.030, respectively); overall advanced stage was an independent prognostic factor for OS (P = 0.020). Surgical extent, elective neck dissection, and postoperative adjuvant radiotherapy did not significantly affect treatment outcomes.

Conclusions

Patients with early-stage IGSGC of parotid origin can achieve favorable treatment outcomes with conservative surgery alone.

Clinical trial identification

Legal entity responsible for the study

no

Funding

None

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.